摘要
目的 :定量检测狼疮肾炎 (LN)患者的sHLA -Ⅰ类分子水平 ,并对其变化的可能机制从分子水平作初步探讨。方法 :ELISA双抗夹心法检测血浆的sHLA -Ⅰ类分子水平 ;RT -PCR检测PBMCHLA -Ⅰ类分子α链mRNA的表达水平。结果 :2 3例LN患者的血浆sHLA -Ⅰ类分子水平为 (96 1.40± 32 4.2 4) μg/L ,LN患者与正常人相比明显增高 (P <0 .0 1) ;LN患者PBMCHLA -Ⅰ类分子α3 结构域 -C末端及变位剪接片段mRNA表达水平明显高于正常人 (P <0 .0 1,P <0 .0 5 )。结论 :LN患者血浆的sHLA -Ⅰ类分子水平明显增高 ,增高的可能机制之一是PBMCHLA -Ⅰ类分子α链变位剪接 ,使得 39KD的sHLA
Objective:To quantify soluble HLA Class Ⅰ (sHLA-Ⅰ)molecules,to study the expression levels of PBMC HLA-Ⅰ molecule α chain mRNA in patients with Lupus nephritis(LN),and to investigate the molecular mechanism of changes in plasma levels of sHLA-Ⅰ molecules in patients with LN.Methods:The plasma levels of sHLA-Ⅰ molecules were measured by sandwich enzyme-linked immunosorbent assay.PBMC HLA-Ⅰ molecule α chain mRNA levels were tested by RT-PCR.Results:The plasma sHLA-Ⅰ molecule concentration was 961.40±324.24μg/L in 23 patients with LN,and 522.45±162.04μg/L in 24 normal controls,revealing significantly difference between them(P<0.01);The LN patients PBMC HLA-Ⅰ molecule α 3 domain-carboxyl terminal and the alternatively spliced mRNA levels increased than those of normal controls(P<0.01,P<0.05).Conclusions:The plasma sHLA-Ⅰ molecule concentration in patients with LN is higher than normal controls,and one of the possible mechanism of the increased plasma levels of sHLA-Ⅰ molecule concentration in LN patients is the PBMC HLA-Ⅰ molecule α chain alternatively spliced mRNA increased,resulting in the elevation of the 39 KD sHLA-Ⅰ molecule.
出处
《中国现代医学杂志》
CAS
CSCD
2001年第8期36-37,共2页
China Journal of Modern Medicine
关键词
狼疮性肾炎
可溶性人类白细胞抗原
逆转录聚合酶链反应信使
Lupus Nephritis
Soluble Human Leukocyte Antigens(sHLA)
Reverse Transcriptase Polymerase Chain Reaction
Untranslated Regions